Compare Suven Life Sciences with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs NEULAND LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES NEULAND LABS SUVEN LIFE SCIENCES/
NEULAND LABS
 
P/E (TTM) x -88.0 63.9 - View Chart
P/BV x 1.4 4.8 28.6% View Chart
Dividend Yield % 1.7 0.1 2,225.3%  

Financials

 SUVEN LIFE SCIENCES   NEULAND LABS
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
NEULAND LABS
Mar-20
SUVEN LIFE SCIENCES/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs338754 44.8%   
Low Rs169247 68.5%   
Sales per share (Unadj.) Rs52.1594.5 8.8%  
Earnings per share (Unadj.) Rs6.812.6 54.1%  
Cash flow per share (Unadj.) Rs8.637.0 23.2%  
Dividends per share (Unadj.) Rs1.502.00 75.0%  
Dividend yield (eoy) %0.60.4 148.0%  
Book value per share (Unadj.) Rs65.3553.4 11.8%  
Shares outstanding (eoy) m127.2812.83 992.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.90.8 577.8%   
Avg P/E ratio x37.139.6 93.7%  
P/CF ratio (eoy) x29.613.5 218.8%  
Price / Book Value ratio x3.90.9 429.4%  
Dividend payout %22.015.8 138.7%   
Avg Mkt Cap Rs m32,2726,421 502.6%   
No. of employees `0001.11.3 84.4%   
Total wages/salary Rs m6611,236 53.5%   
Avg. sales/employee Rs Th6,132.25,949.4 103.1%   
Avg. wages/employee Rs Th611.1963.8 63.4%   
Avg. net profit/employee Rs Th803.5126.4 635.6%   
INCOME DATA
Net Sales Rs m6,6357,627 87.0%  
Other income Rs m24239 623.7%   
Total revenues Rs m6,8777,666 89.7%   
Gross profit Rs m1,6041,019 157.4%  
Depreciation Rs m221313 70.8%   
Interest Rs m38216 17.5%   
Profit before tax Rs m1,587529 300.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718367 195.6%   
Profit after tax Rs m869162 536.4%  
Gross profit margin %24.213.4 181.0%  
Effective tax rate %45.269.4 65.2%   
Net profit margin %13.12.1 616.6%  
BALANCE SHEET DATA
Current assets Rs m6,2325,152 121.0%   
Current liabilities Rs m1,4903,576 41.7%   
Net working cap to sales %71.520.7 346.0%  
Current ratio x4.21.4 290.3%  
Inventory Days Days86105 82.3%  
Debtors Days Days8391 90.9%  
Net fixed assets Rs m4,0433,969 101.9%   
Share capital Rs m127129 98.7%   
"Free" reserves Rs m8,1836,971 117.4%   
Net worth Rs m8,3107,100 117.0%   
Long term debt Rs m18774 2.3%   
Total assets Rs m10,38912,310 84.4%  
Interest coverage x43.13.5 1,248.3%   
Debt to equity ratio x00.1 2.0%  
Sales to assets ratio x0.60.6 103.1%   
Return on assets %8.73.1 284.5%  
Return on equity %10.52.3 458.3%  
Return on capital %19.59.5 206.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,6225,187 108.4%   
Fx outflow Rs m1,7991,593 113.0%   
Net fx Rs m3,8223,594 106.4%   
CASH FLOW
From Operations Rs m356573 62.0%  
From Investments Rs m-279-487 57.2%  
From Financial Activity Rs m-225-55 410.8%  
Net Cashflow Rs m-14833 -454.6%  

Share Holding

Indian Promoters % 63.4 36.3 174.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 63.7 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 63.7 57.3%  
Shareholders   37,287 12,705 293.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  UNICHEM LAB  

Compare SUVEN LIFE SCIENCES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Apr 20, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - ABBOTT INDIA COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS